BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zelli V, Compagnoni C, Capelli R, Corrente A, Di Vito Nolfi M, Zazzeroni F, Alesse E, Tessitore A. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma. Front Oncol 2022;12:940056. [DOI: 10.3389/fonc.2022.940056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Wang Y, Gao P, Ding J. Immune checkpoint inhibitor resistance in hepatocellular carcinoma. Cancer Lett 2023;555:216038. [PMID: 36529238 DOI: 10.1016/j.canlet.2022.216038] [Reference Citation Analysis]
2 Matsuzaka Y, Yashiro R. Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments. Membranes (Basel) 2022;12. [PMID: 36557150 DOI: 10.3390/membranes12121244] [Reference Citation Analysis]
3 Paramanantham A, Asfiya R, Das S, Mccully G, Srivastava A. Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics. IJMS 2022;23:13637. [DOI: 10.3390/ijms232113637] [Reference Citation Analysis]